These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36212476)

  • 21. Dynamic N6-methyladenosine modification of lncRNA modulated by METTL3 during bacterial disease development in an echinoderm.
    Zhang S; Shao Y; Li D; Li C
    Fish Shellfish Immunol; 2022 May; 124():497-504. PubMed ID: 35483599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. m6A Methyltransferase METTL3 Reduces Hippocampal Neuron Apoptosis in a Mouse Model of Autism Through the MALAT1/SFRP2/Wnt/β-catenin Axis.
    Ming Y; Deng Z; Tian X; Jia Y; Ning M; Cheng S
    Psychiatry Investig; 2022 Oct; 19(10):771-787. PubMed ID: 36327957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis.
    Tang T; Huang X; Zhang G; Lu M; Hong Z; Wang M; Huang J; Zhi X; Liang T
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35288467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WDR5-H3K4me3 epigenetic axis regulates OPN expression to compensate PD-L1 function to promote pancreatic cancer immune escape.
    Lu C; Liu Z; Klement JD; Yang D; Merting AD; Poschel D; Albers T; Waller JL; Shi H; Liu K
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34326167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. METTL3-induced FGD5-AS1 contributes to the tumorigenesis and PD-1/PD-L1 checkpoint to enhance the resistance to paclitaxel of endometrial carcinoma.
    Hao M; Li T; Xiao L; Liu Y
    J Cell Mol Med; 2023 Sep; 28(5):e17971. PubMed ID: 37755125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpressed histone acetyltransferase 1 regulates cancer immunity by increasing programmed death-ligand 1 expression in pancreatic cancer.
    Fan P; Zhao J; Meng Z; Wu H; Wang B; Wu H; Jin X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):47. PubMed ID: 30709380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. METTL3-Mediated lncRNA m
    Song Y; Pan Y; Wu M; Sun W; Luo L; Zhao Z; Liu J
    Stem Cell Rev Rep; 2021 Dec; 17(6):2276-2290. PubMed ID: 34505967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis.
    Huang Y; Xia L; Tan X; Zhang J; Zeng W; Tan B; Yu X; Fang W; Yang Z
    Cell Mol Biol Lett; 2022 Jun; 27(1):43. PubMed ID: 35658874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling.
    Zhou Y; Shan T; Ding W; Hua Z; Shen Y; Lu Z; Chen B; Dai T
    J Cell Physiol; 2018 Aug; 233(8):5805-5814. PubMed ID: 29215734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion.
    Xia T; Wu X; Cao M; Zhang P; Shi G; Zhang J; Lu Z; Wu P; Cai B; Miao Y; Jiang K
    Pathol Res Pract; 2019 Nov; 215(11):152666. PubMed ID: 31606241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of methyltransferase-like enzyme 3 and methyltransferase-like enzyme 14 in urological cancers.
    Tao Z; Zhao Y; Chen X
    PeerJ; 2020; 8():e9589. PubMed ID: 32765970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the prognostic significance and potential mechanisms of lncRNAs associated with m6A methylation in papillary thyroid carcinoma.
    Huang Y; Li X; Chen W; He Y; Wu S; Li X; Hou B; Wang S; He Y; Jiang H; Lun Y; Zhang J
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108286. PubMed ID: 34735975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune Infiltrates of m
    Feng ZY; Gao HY; Feng TD
    Front Cell Dev Biol; 2021; 9():672248. PubMed ID: 34178999
    [No Abstract]   [Full Text] [Related]  

  • 35. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
    Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
    Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors.
    Zhang X; Lao M; Xu J; Duan Y; Yang H; Li M; Ying H; He L; Sun K; Guo C; Chen W; Jiang H; Zhang X; Bai X; Liang T
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35260434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNAs XIST and MALAT1 hijack the PD-L1 regulatory signaling pathway in breast cancer subtypes.
    Samir A; Tawab RA; El Tayebi HM
    Oncol Lett; 2021 Aug; 22(2):593. PubMed ID: 34149904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis and prognostic significance of tumour immune infiltrates and immune microenvironment of m6A-related lncRNAs in patients with gastric cancer.
    Huang J; Song J; Li X; Liu S; Huang W; Shen Z; Cheng Y; Kou S; Gao Z; Tian Y; Hu J
    BMC Med Genomics; 2022 Jul; 15(1):164. PubMed ID: 35879790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA MALAT1 overexpression is an unfavorable prognostic factor in human cancer: evidence from a meta-analysis.
    Zhang J; Zhang B; Wang T; Wang H
    Int J Clin Exp Med; 2015; 8(4):5499-505. PubMed ID: 26131129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PD-1/PD-L1 expression in pancreatic cancer and its implication in novel therapies.
    Mucileanu A; Chira R; Mircea PA
    Med Pharm Rep; 2021 Oct; 94(4):402-410. PubMed ID: 36105495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.